Stroke/Vascular Neurology News

The initial diagnosis of non-ischemic events, or “stroke mimics,” occurred more frequently in women than men in a secondary analysis of DOUBT study data, though diagnostic revisions were often made for both men and women.

Among patients with COVID-19, those who had hypertension or type 2 diabetes were more likely to develop neurological conditions associated with the infectious disease, data from a small study show.

On the third Thursday of each November, the American Cancer Society encourages the estimated 32.4 million smokers in the United States to begin the “journey to a smoke-free life” in the “Great American Smokeout.”

In new data from the THALES trial of patients with prior stroke, the benefit of ticagrelor plus aspirin for secondary stroke prevention was greatest in those with ipsilateral atherosclerotic stenosis.

Collaboration across disciplines and bridging connections between science and practice is imperative if today’s challenges — from COVID-19 to racial disparities — are to be resolved, according to the American Heart Association’s president.

Results presented at the Virtual EFORT Congress showed an association between the CHA2DS2-VASc score with risk of stroke, thromboembolism and death among patients with or without atrial fibrillation undergoing treatment for hip fracture.

Among Black patients with lupus, the risk for stroke is three times higher than white patients, and the risk for ischemic heart disease is 24 times higher, according to a presenter at ACR Convergence 2020 virtual meeting.

AstraZeneca announced the FDA approved its P2Y12 inhibitor ticagrelor for the reduction of stroke risk among patients with acute ischemic stroke or high-risk transient ischemic attack.

A large proportion of young adults in the United States may not be aware of stroke symptoms, according to study results published in Stroke.

Noncommunicable neurological disorders resulted in “a large and increasing burden” in the United States, according to a systematic analysis of the Global Burden of Disease study from 2017 that was published in JAMA Neurology.